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Abstract: Scleroderma (or systemic sclerosis, SSc) is a disease caused by excess crosslinking 
of collagen. The skin stiffens and becomes painful, while internally, organ function can be 
compromised by the less elastic collagen. Diagnosis of SSc is often only possible in advanced 
cases by which treatment time is limited. A more detailed analysis of SSc may provide better 
future treatment options and information of disease progression. Recently, the histological stain 
picrosirius red showing collagen register has been combined with atomic force microscopy 
(AFM) to study SSc. Skin from healthy individuals and SSc patients was biopsied, stained and 
studied using AFM. By investigating the crosslinking of collagen at a smaller hierarchical stage, 
the effects of SSc were more pronounced. Changes in morphology and Young’s elastic modulus 
were observed and quantified; giving rise to a novel technique, we have termed “quantitative 
nanohistology”. An increase in nanoscale stiffness in the collagen for SSc compared with healthy 
individuals was seen by a significant increase in the Young’s modulus profile for the collagen. 
These markers of stiffer collagen in SSc are similar to the symptoms experienced by patients, 
giving additional hope that in the future, nanohistology using AFM can be readily applied as a 
clinical tool, providing detailed information of the state of collagen.
Keywords: rheumatology, adjunct diagnosis, picrosirius red, collagen, nanohistology
Introduction
Scleroderma, or systemic sclerosis (SSc), is a multisystemic collagen disorder of inde-
terminate etiology.1,2 It can be characterized primarily by the severe fibrosis of skin 
and viscera, but widespread vasculopathy and a spectrum of other features can arise.2 
SSc can cause significant physical impairment, reducing the patient’s quality of life.3 
SSc occurs globally with females significantly more often diagnosed than males.4 The 
precise cause of scleroderma remains unknown, although there can be similarities with 
exposure to organic solvents.5,6 There are two broad types of SSc, denoted as limited 
and diffuse cutaneous SSc.7–9 Limited cutaneous SSc primarily causes vasculopathy 
with slow fibrosis, whereas diffuse cutaneous SSc is dominated by the rapid fibrosis of 
skin and organs. There have been significant advances in the management of SSc over 
the past 2 decades, and a wide range of new biological agents will hopefully prove to 
be of clinical benefit. Nevertheless, at present, the disease can lessen life expectancy 
with 55% of patients dying within 10 years of diagnosis of diffuse SSc.10,11 While there 
are a number of biomarkers of SSc (eg, various autoantibodies), there remains no one 
sensitive diagnostic tool; hence, as a consequence of its relative rarity and the absence 
of sensitive biomarkers, SSc may go undetected for several years after clinical onset, 
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and thus, opportunities to modify disease progress are lost. 
Improvements to clinical care and condition management 
have increased patient life expectancy. The rapid onset of SSc 
combined with difficulties in early diagnosis is considered 
to the possible reason for the high mortality rate associated 
with this condition.12
The diagnosis of the disease is performed through 
clinical investigation via a differential diagnosis approach. 
To date, there is no conclusive genetic or biomarker diag-
nosis for SSc.13 Histological biopsies can prove useful in 
later-stage SSc, but after the disease has progressed, a 
visual assessment in clinic is often sufficient. Avoiding 
the collection of biopsies would avoid the exacerbation of 
scarring in SSc patients.14 Currently, the diagnosis of SSc 
often occurs at a late stage, although there is an ongoing 
need for earlier-stage diagnosis.3,6,12 Some advances in the 
detection of biomarkers have already been made, but these 
are not suitable for a frontline diagnosis.3 Similarly, there 
are very few methods that are used to detect the spread 
of SSc. Optical coherence tomography (OCT) is a nonin-
vasive tool that could potentially be used to analyze SSc. 
However, current OCT research is unable to distinguish 
between the density of healthy skin, keloid scar formation 
and an SSc lesion.15
Although SSc is a collagenous disorder, it is often referred 
to as a skin condition, and the effects on other tissues can be 
overlooked.5,11,12 The effects of SSc on skin are often the first 
to be noticed by the patient, and skin is an easily accessible 
and well-characterized tissue. SSc is believed to be associated 
with an excess of collagen crosslinking from lysyl oxidase 
and other enzymes noted as a possible cause.16 The impact 
of this excessive number of crosslinks within SSc lesions 
would confer both structural and mechanical abnormalities 
to collagen fibrils present in these lesions. However, to date, 
there has been no research effort to investigate the biophysi-
cal properties of collagen in relation to SSc patients in order 
to further understand the onset of this condition. The limited 
amount of research that has been performed on laboratory 
cell models is decades old.17
In this article, a novel approach is presented to gain fur-
ther information on the biophysical properties (topographi-
cal and nanomechanical) of the collagen network present 
in the SSc lesions using atomic force microscopy (AFM) 
combined with histology. The probing of these physical 
parameters at the scale where the disease is starting to impact 
the tissue may demonstrate the physical alterations occurring 
in collagen as a result of SSc. This could provide a future 
method of assessing disease progress and help to determine 
if new therapies are having a benefit at the molecular and 
tissue level.
Materials and methods
All samples were obtained under ethical approval: Research 
Ethics Committee, Cambridge, UK, 06/6398 and patient 
consent was obtained following local guidelines. Volunteer 
patients had a 4 mm punch biopsy taken from the upper forearm 
in a non-load-bearing area, including the sclerotic lesion where 
appropriate for this study. One healthy control volunteer and 
one patient with SSc were included in this study. Both individu-
als were male white Caucasians, approximately 60 years old. 
The SSc patient was diagnosed in clinic as being at a severe 
stage of the disease, ensuring that any samples taken would 
have sclerotic lesions. Samples were snap-frozen in methyl 
butane and liquid nitrogen. Samples were histologically cut 
into 10 µm sections at a clinical laboratory (Blizard Institute 
– Queen Mary University, London, UK). The sections were 
subsequently stained with picrosirius red (PS) for collagen after 
being dried through physisorption onto a glass slide. The pre-
pared sections were then stored at 4°C under Human Tissue Act 
(2004) guidelines until required for experiments. No further 
processing was required for light microscopy (LM) histology 
or AFM characterization. For imaging by electron microscopy 
(EM), the sections were also fixed for 24 hours in 3% glutaral-
dehyde (Agar Scientific, Stansted, UK) and dehydrated using 
an ethanol series, before being coated with Au/Pd.
A Leica (Wetzlar, Germany) light microscope with 4×, 
10×, 20× and 50× magnification lenses, equipped with two 
crossed-light polarizers (90°), was used for polarized LM. 
At least three images were taken in each location for each 
sample, with at least three biopsies per patient analyzed. 
Images were captured using an 8-megapixel digital camera 
(EOS Rebel 100, Canon).
EM imaging was performed using a Philips XL30 FEG-
SEM (FEI, Eindhoven, the Netherlands), at an accelerating 
voltage of 5 kV. Two AFMs were used to collect imaging 
and force–displacement (FD) measurement. At least three 
images were taken in each location for each sample, with at 
least three biopsies per patient analyzed. A Nanowizard (JPK, 
Berlin, Germany) with REFSPA tips (k=3 N/m) (Bruker, 
Santa Barbara, CA, USA) in contact mode in air was used 
to collect FD. Imaging was also performed on Dimension 
3100 (Bruker) AFM in contact mode in air. Both AFMs used 
MSNL-10 (Bruker) probes in imaging mode. For all AFM 
measurements, the samples were kept air-dried to avoid the 
delamination of the sections upon rehydration. FD curves 
were analyzed on proprietary software (JPK). FD values were 
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extracted, and the Young’s modulus was calculated using the 
Oliver–Pharr model.18 These data were statistically analyzed 
using Kruskal–Wallis analysis of variance and plotted using 
Origin (OriginCorp, Northampton, MA, USA) processing 
software. At least three data sets were taken in each location for 
each sample, with at least three biopsies per patient analyzed, 
for a minimal of 350 force curves per location. Post-statistical 
analysis was performed manually by grouping samples into 
four empirically observed groups (1–5, 5–10, 10–15 and 
15–20 GPa), and describing the percentage distribution 
of n-number values. These were plotted on the previously 
formed graphs.
Results and discussion
histological comparison between healthy 
vs ssc dermal layers
In order to ensure that our approach is clinically relevant, it 
was essential to start our investigation by using histology as a 
first approach to compare both healthy and SSc dermal layers. 
Figure 1A shows the histology of healthy control skin. The 
epidermal layer is clearly defined as a thick brown-red layer 
at the top of the skin. The dermoepidermal junction (DEJ) 
is demarcated by a color change from brown-red to pink-
red. The dermal layer is porous with large gaps intercalated 
between collagen-stratified layers. In healthy dermis, fibrillar 
collagen aggregates to form larger bundles of fibers and is 
the structural protein which provides mechanical support to 
connective tissues throughout the body.19 The bundles align 
in register with each other, forming three-dimensional (3D) 
collagen sheets. These sheets of fibers are found mainly in the 
reticular dermis of the skin, which is 80% type I collagen.20 
The 3D alignment and order of the collagen provide isotropic 
mechanical strength to the skin.21 Collagen can support these 
mechanical loads due to crosslinking of collagen molecules 
and the formation of a hierarchal structure.22 Figure 1B 
shows the polarized light histology of the healthy skin. The 
change in color on the control sample is difficult to see, and 
the dermal layer stained with PS is still pink-red. It is known 
that staining with PS does not show just collagen, but the 
register of the collagen.23 Sirus red, a component of PS, is a 
strong anionic dye. The sulfonic acid groups on sirus red react 
with basic groups present in the collagen molecule. Sirus red 
and collagen align so that their long axes are parallel, which 
correspond to the long axis of the fibrils. This enhances the 
birefringence of collagen.23 As PS aligns to the register of 
collagen fibrils, any changes from red to another color in 
the polarized image suggest that the collagen fibrils may 
no longer be in register and that the collagen scaffold may 
be structurally disordered (when compared to well-ordered 
collagen sheet in healthy dermis for example).
Figure 1C shows the histology of SSc. The epidermal 
layer is colored brown but appears thinner than the control. 
The DEJ is not well defined, as the dermis appears to bulge 
into the epidermis. The dermal layer appears denser than the 
Figure 1 lM images of control (A and B) and ssc (C and D) biopsies taken in unpolarized and polarized light (10× magnification).
Abbreviations: lM, light microscopy; ssc, systemic sclerosis.
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control, with far fewer gaps between the collagen-stratified 
layers. The reticular dermis also bulges out past the edge of 
the epidermis. Collagen production is known to increase in 
SSc, so the increase in density and loss of gap regions in the 
SSc sample as viewed under LM is expected. The bulging 
of the dermis past the edge of the epidermis is known as a 
“cookie-cutter bulge” and is a reported histological feature 
of SSc.13 Figure 1D shows the SSc under polarized light. The 
color changes are notable, and red, yellow and green regions 
could be clearly identified, without any color appearing to 
be more prevalent than another. By combining histological 
imaging with PS staining, we can observe areas of color 
change which show different levels of collagen birefringence 
suggesting different levels of structural ordering of the 
underlying collagen fibrils. Although this could be sufficient 
in aiding in a clinical diagnosis, more information about the 
state of collagen needs to be obtained to explain this lack of 
structural ordering as a potential marker for SSc.
Structural ordering of collagen fibrils
In order to investigate the structural properties of the col-
lagen scaffold within the dermal layer, the samples were 
imaged using EM so that both large-field and localized 
high-resolution images could be obtained on the same 
samples. Figure 2 shows representative images of skin 
biopsies obtained through scanning electron microscopy 
(SEM). The control sample (Figure 2A) shows a represen-
tative image from the epidermis. There is a thick sheet-like 
layer of collagen, with a clearly defined swirling pattern. The 
swirling pattern has been reported as a sign of dermal aging. 
The preparation process for SEM caused desiccation cracks, 
and a small number is visible between the collagen swirls. At 
this magnification (1,000×), the individual fibrils are not yet 
fully visible. Figure 2B was imaged at a higher magnifica-
tion (15,000×), and the collagen fibrils can be seen, and the 
D-banding periodicity resolved. The collagen fibrils are in 
register and well ordered, following a clear left–right axis 
across the image. Figure 2C shows the SSc sample at 1,000× 
magnification. Larger gaps between the collagen sheets can 
now be seen, and some individual fibrils may be resolved. 
Figure 2D was imaged at 15,000× magnification, and there 
is a notable loss of collagen register. The circled area shows 
a particular disordered area, where the collagen lacks any 
register. However, the D-banding periodicity can be clearly 
resolved confirming the presence of collagen. As far as SEM 
imaging can tell us, the collagen appears to be well formed 
Figure 2 seM images of control (A and B) and ssc (C and D).
Notes: scale bars of (A) and (C): 20 µm, 1,000× magnification; scale bars of (B) and (D): 2 µm, 15,000× magnification. Circled area in (D) shows an area of high collagen 
disorder due to ssc.
Abbreviations: seM, scanning electron microscopy; ssc, systemic sclerosis.
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as the D-banding appears regular, with no pitting, swelling 
or blebbing observed.24–26
SEM allowed for surface topographical analysis over a 
range of magnifications. When the polarized LM images 
were used, the color changes seen in the SSc sample implied 
a loss of collagen register. The control samples lacked a 
color change, and regular and ordered structure was seen 
throughout the SEM images at both magnification levels. 
This reconfirms that the PS stain indicates a change of 
collagen ultrastructural register. When both the control 
and SSc images are compared, it becomes evident that the 
main structural change relates to the lack of interfibrillar 
registration. Being a connective tissue that is subject to 
various posttranslational modifications, collagen evolves 
as we age but also as a result of disease such as SSc. In a 
healthy tissue, collagen fibrils are stabilized by a series of 
crosslinks that can be classified as intramolecular, intermo-
lecular (or intrafibrillar) and also interfibrillar. Although at 
this stage, we have not yet elucidated the crosslinks density 
on collagen fibrils associated with SSc, we hypothesize two 
mechanisms that could explain the lack of register between 
collagen fibrils within an SSc lesion: sclerotic fibrils are 
unable to adjust their register due to an increase in collagen 
stiffness caused by excess of intrafibrillar crosslinking. This 
crosslinking acts as a pathological collagen fixative, keeping 
the collagen in a disordered state of register. The second 
hypothesis would suggest that the interfibrillar crosslinks 
may have become deficient and leads to a loosening of the 
collagen organization within the dermis. It is known from 
clinic that SSc causes stiffening in patients, most notice-
ably in the skin; it is therefore unlikely that the collagen 
organization loosens due to crosslink weakness. It has 
therefore been suggested that SSc, in a similar manner to 
diabetes, arises due to a pathological increase in collagen 
crosslinking.27
Nanomechanics of collagen in dermal 
layer
Nanoscale analysis can be performed by AFM which has sev-
eral advantages over SEM in looking at collagen in SSc. 
AFM can be performed in ambient laboratory conditions 
and easily allows for mechanical parameters, such as 
the Young’s elastic modulus, to be measured.18 It is clear 
that collagen stiffening is an important parameter to take 
into account while characterizing SSc. In our approach, 
we have used an AFM to probe the mechanical properties 
of individual collagen fibrils present in the dermal layer of 
each series of samples. The AFM probe is small enough so 
that individual fibrils can be indented separately. Before 
undertaking this approach to elucidate the collagen stiffening 
in SSc, it is essential to perform these measurements on the 
control sample for reference. Figure 3A shows the sample 
imaged with LM, and four areas were randomly selected 
and highlighted for further AFM study on a healthy control 
sample. Figure 3B shows AFM topographical imaging of 
area D for example. The ultrastructure of collagen fibrils can 
be identified by means of the D-banding present along the 
long-fibril axis. In this particular area, three distinct sheets 
were imaged, appearing in the left, middle and right thirds 
of the image. This image highlights the structural complex-
ity and isotropy of the dermis in which several collagen 
sheets may intercept each other, presenting collagen fibrils 
cross-sections, in-plane section (D-banding) or an oblique 
section. Thus, to be systematic, only collagen fibrils that 
were in plane (clear D-banding) with the AFM scan were 
then mechanically probed using FD. Figure 3C shows the 
distribution of reduced Young’s modulus obtained from the 
healthy sample after being calculated using the Oliver–Pharr 
model.18 Comparing the data obtained from the four different 
locations probed, it was not possible to observe any meaning-
ful variation in the reduced Young’s modulus (Figure 3C). 
None of the four areas analyzed were statistically different 
compared to each other (P.0.05, Kruskal–Wallis). It is 
however worth noting that for all the locations tested, it 
was found that over 60% of the collagen indented (n$225) 
had a reduced Young’s modulus ,10 GPa. The range of 
reduced Young’s moduli values in the skin (Figure 3C) is 
consistent with published data on collagen fibrils in com-
parable conditions.28,29
Toward quantitative nanohistology
By combining histological imaging, nanoscale imaging and 
nanoscale indentation, we have created a protocol termed 
“quantitative nanohistology” (QNH). This allows us to 
quantify the amount of collagen disorder observed at the 
nanoscale with no additional sample preparation other than 
what is commonly used in histology.
Figure 4 demonstrates the imaging part of the QNH 
profile for the healthy control sample. Figure 4A shows the 
polarized LM image. It can be seen that the majority of the 
sample is red in color. There are areas of yellow and green 
also present. Four areas selected for AFM are highlighted on 
the image. Figure 4B shows the topographical AFM image 
of the red area, taken from the highlighted area in Figure 4A. 
D-banding can be readily observed, confirming that the fibrils 
are collagen. Figure 4C demonstrates the AFM image of the 
green area as highlighted in Figure 4A. Some collagen can 
be seen toward the bottom of the image, but a large section 
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does not contain D-banded collagen. This is consistent with 
what is known about PS staining, as the larger amount of 
non-register collagen caused the green color to be seen under 
polarized LM.30 Figure 4D demonstrates a magnified area in 
Figure 4B. The collagen is in register, and as can be seen 
in the Figure 4D insert, the D-banding is regular at 65.8 nm 
periodicity, compared with a reported average of 67 nm.31 
Figure 5A shows the calculated Young’s modulus values 
from the FD curves. Bimodal distribution was seen in the 
red area, with peaks in the ,5 and 10–15 GPa categories 
(N=312). Bimodal distribution of collagen has been reported 
previously, with lower Young’s moduli values suggested to 
be newer collagen, and higher Young’s moduli values older 
collagen, when further crosslinking has occurred.32 Similar 
bimodal distribution was seen in the red/yellow area. No 
bimodal distribution was seen in the yellow or green areas, 
with 72% (N=345) and 83% (N=376) of all values ,10 GPa. 
All colors had their largest percentage values in the 0–5 GPa 
categories. When analyzed using mean averages as a whole 
data set using Kruskal–Wallis test, the red (8.81 GPa) and 
red/yellow (7.56 GPa) areas were not significantly different 
(P.0.05). Significantly lower values (P#0.05) were found 
for the red value compared with yellow (6.84 GPa) and 
green (5.23 GPa).
There were very few red areas under the polarized LM. 
This is expected for control skin, and following the published 
literature, it is believed that this region should show collagen 
that is in register.23 When looking at the AFM imaging, it was 
clear that the collagen was not in register. As each individual 
PS molecule will lie along several collagen molecules, the 
natural birefringence of collagen is enhanced. When com-
bined with many other PS molecules, this acts as a method 
of indicating the nanoscale register at the microscale. How-
ever, nanoscale-localized imperfections in register would be 
expected to still show as red under polarized LM. The AFM 
image of the healthy collagen demonstrates an imperfect 
collagen register, but one that is nevertheless very well 
aligned. The significant differences in Young’s modulus are 
Figure 3 aFM analysis of control skin sample in random locations. (A) standard lM was performed on a healthy control skin sample, and four areas of interest (a–D) were 
marked (10× magnification). (B) aFM image of area D from (A), showing interface between three different collagen regions (scale bar 2 µm). (C) Young’s modulus obtained 
by transverse collagen on fibrils in locations A–D from (A). No areas were significantly different, P,0.05 (Kruskal–Wallis).
Abbreviations: aFM, atomic force microscopy; lM, light microscopy.
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Figure 4 aFM analysis of control skin sample. (A) Polarized lM showing red, red/yellow, yellow and green areas of interest (10× magnification). (B) aFM error image of 
red area showing collagen present and highlighting an area of collagen (scale bar 2 µm). (C) aFM error image of green area showing minimal intact collagen (scale bar 2 µm). 
(D) AFM error image of highlighted red area with inset showing a line profile from the height image (scale bar 800 nm).
Abbreviations: aFM, atomic force microscopy; g, green; lM, light microscopy; r, red; r/Y, red/yellow; Y, yellow.
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consistent with what is known about PS. The Young’s moduli 
for red and red/yellow are consistent with the values given in 
literature.28,29 The red collagen, which is the best indication 
available for healthy in-register collagen, was used as the 
QNH “fingerprint” for Young’s modulus.
QNh – ssc
Figure 6 shows the complete imaging QNH profile for the 
SSc sample. Figure 6A demonstrates the polarized LM of the 
SSc sample. It shows no dominant color, with red, yellow 
and green all present. Four areas for FD are highlighted on 
the image. Figure 6B shows the topographical AFM image 
of the red area, highlighted from Figure 6A. The fibrils show 
D-banding, confirming that the fibrils are collagen. The 
collagen is not in register, with no discernible directional orig-
ination, which is consistent with the SEM data in Figure 2D, 
specifically the circled area. Figure 6C shows a magnified 
green area, as indicated in Figure 6A. D-banded collagen can 
be seen around the edge of the image, with a large amount of 
protein covering the center of the image. This protein could 
be hydrolyzed collagen (ie, gelatin) or a non-collagenous 
protein.33 Irrespective of its chemical makeup, it covers the 
underlying collagen and prevents the PS molecules from lying 
on the collagen D-band. Therefore, this area appears green 
under polarized microscopy. Figure 6D shows a magnified 
area of Figure 6B. The collagen, although out of register, 
has regular D-banding which can be seen in the insert. The 
average D-band for this area was 64.2 nm, comparing favor-
ably with the reported average of 67 nm.31 Figure 5B shows 
the indentation performed on identifiable collagen in the 
sample. The red area had its largest percentages of values 
in the 10–15 GPa (32%, N=151) and the 15–20 GPa (30%, 
N=141) range. The red/yellow area had most of the values 
(46%, N=178) in the 5–10 GPa category, with 23% (N=89) 
in the 15–20 GPa category. The yellow and green areas had 
89% (N=373) and 94% (N=370) of values ,10 GPa.
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Figure 5 Young’s modulus values for control and ssc skin samples. (A) Young’s modulus obtained by transverse indentation on collagen fibrils in each area. Yellow and green 
areas are statistically different (indicated with asterisks) compared with red, P.0.05 (Kruskal–Wallis aNOVa). (B) Young’s modulus obtained by transverse indentation on 
collagen fibrils in each area. Red/yellow, yellow and green areas are statistically different (indicated with asterisks) compared with red, P.0.05 (Kruskal–Wallis aNOVa).
Abbreviations: aNOVa, analysis of variance; g, green; r, red; r/Y, red/yellow; ssc, systemic sclerosis; Y, yellow.
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Figure 6 aFM analysis of ssc skin sample. (A) Polarized lM showing red, red/yellow, yellow and green areas of interest (10× magnification). (B) aFM error image of red 
area showing collagen present and highlighting an area of collagen (scale bar 2 µm). (C) aFM error image of green area showing minimal intact collagen (scale bar 2 µm). 
(D) AFM error image of highlighted red area with inset showing a line profile from the height image (scale bar 800 nm).
Abbreviations: aFM, atomic force microscopy; g, green; lM, light microscopy; r, red; r/Y, red/yellow; ssc, systemic sclerosis; Y, yellow.
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Nanohistology in scleroderma
There is an immediately noticeable difference in LM 
between the control and the SSc sample. In the SSc sample, 
there is no dominant color suggesting a higher level of dis-
order in the SSc sample compared with the control. The LM 
provides a direct microscopic analysis of the ordering of the 
collagen in the sample, but there is no quantification provided 
by this method. The AFM in the red area also showed marked 
differences between the control and SSc image. The fibrils 
in SSc are not in register, and there is localized swelling, 
while the D-banding is always visible. The lack of register is 
concerning, as this is not a sign of healthy collagen.34,35 The 
Young’s modulus values for the red areas were consistently 
higher for SSc than control. At the macroscale, SSc causes 
collagen hardening in patients. The green values were not 
statistically different for both samples (Figure 5A and B). 
We believe that this is due to the large amount of non-
morphologically identifiable collagen seen in the green areas 
(Figures 4C and 6C). As SSc is only known to affect collagen, 
it is not unexpected that the non-collagenous regions are 
similar between healthy individuals and SSc patients.
However, we hypothesize that the disorder seen in SSc 
patients can be directly linked to the increase in Young’s 
modulus measured for SSc (Figure 5B). The result of this 
high stiffness is that fibrils are incapable of forming the 
correct bundling structure; instead, they are not in register 
and are poorly aligned (Figures 2D and 6B). The severe dif-
ference in stiffness seen in the SSc sample could be linked 
to the severity of the disease in the patient when the sample 
was obtained. Morphologically, there is also evidence of 
localized swelling in several fibrils. When the control and 
SSc are compared morphologically, the differences in the 
ability of the fibrils to maintain their register can be observed 
(Figures 4B and D and 6B and D). The D-banding remained 
similar in appearance for both of the biopsies examined. As 
the D-band is formed as a result of the amino acid makeup of 
collagen, this suggests that the collagen is formed correctly, 
and thus, the excess crosslinking occurs after the formation 
of collagen. This matches well with what is currently known 
about SSc, in that there is no known genetic cause.6,11 If the 
collagen is formed correctly, we then hypothesize that the 
crosslinking is interfibrillar.
Conclusion
Imaging using LM currently remains the gold standard in his-
tology for diagnostic medicine, but there are improvements 
that can be made. The use of PS staining informs the target-
ing of the AFM measurements, giving rise to QNH adjunct 
diagnosis. Through nanoscale AFM imaging, it is possible to 
observe the effects of crosslinking at a point closer to where 
the changes begin, inside the collagen fibrils. This is then 
combined with the mechanical measures to provide a detailed 
indication of the state of the collagen. The nanohistological 
protocol described here has shown that SSc skin collagen 
has significantly higher Young’s modulus than healthy skin 
collagen. Having shown this in a case study of SSc, we 
will then look to expand the number of patients sampled, 
creating a mechanical and morphological database. Having 
established a baseline of severe SSc disorder as observed 
in the clinic and through QNH, we then hope to expand the 
role of AFM directly into the clinic. It could be expanded to 
look at less severe cases of SSc, to mark and observe SSc 
development and activity and to measure patient responses 
to medical interventions. Finally, QNH may one day be used 
as an adjunct diagnostic tool in complex cases of collagen-
based diseases.
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